Article
In vivo rescue of genetic dilated cardiomyopathy by systemic delivery of nexilin.
Genome biology - 23 May 2024
Shao Yanjiao, Liu Canzhao, Liao Hsin-Kai, Zhang Ran, Yuan Baolei, Yang Hanyan, Li Ronghui, Zhu Siting, Fang Xi, Rodriguez Esteban Concepcion, Chen Ju, Izpisua Belmonte Juan Carlos
Abstract excerpt
BACKGROUND: Dilated cardiomyopathy (DCM) is one of the most common causes of heart failure. Multiple identified mutations in nexilin (NEXN) have been suggested to be linked with severe DCM. However, the exact association between multiple mutations of Nexn and DCM remains unclear. Moreover, it is critical for the development of precise and effective therapeutics in treatments of DCM. RESULTS: In our study, Nexn...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
